Implementation of routine access to herpes simplex virus type 2 antibody testing in a public health sexually transmitted disease clinic

Kenneth Fife, Barbara Van Der Pol, Alexis M. Roth, Juanita Brand, Janet Arno, Jyl Madlem, Beth E. Juliar, Barry Katz, James A. Williams, Gregory Zimet, J. Fortenberry

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

BACKGROUND:: Testing for herpes simplex virus type 2 (HSV-2) antibody is not common in clinical practice. Client characteristics associated with HSV-2 rapid antibody test uptake and test positivity were analyzed in clients attending an urban sexually transmitted disease clinic. METHODS:: This optional test was available for $30. The HerpeSelect Express assay was performed on serum. Demographic and behavioral characteristics were compared between clients who requested testing and those who did not and between those who were HSV-2 antibody positive and negative. RESULTS:: In 4 months, 3498 individuals attended the clinic and 443 (12.7%) opted for HSV-2 testing. Clients who were black, younger, or female were less likely to request testing. Recent sexual behavior and self-reported sexual orientation were not associated with uptake of testing. Of the 442 clients with results available, 109 were positive for HSV-2 antibody (24.7%). Women were significantly (P <0.001) more likely to test positive; 42 of 111 (38.4%) versus only 67 of 331 (20.2%) men. A positive HSV-2 antibody test was also associated with increasing age and black race. There was an association with the number of partners in the last 30 days, but no association with the number of partners in the last year. Of the 109 clients who had a positive HSV-2 antibody test, 71 (64.5%) accepted a prescription for suppressive acyclovir therapy. CONCLUSIONS:: Uptake of testing was modest in this population, especially among the highest risk individuals, possibly due to the cost of the test. Improved education regarding HSV-2 and subsidized testing may be needed in the populations that have the highest prevalence in order to encourage testing.

Original languageEnglish
Pages (from-to)724-728
Number of pages5
JournalSexually Transmitted Diseases
Volume36
Issue number11
DOIs
StatePublished - 2009

Fingerprint

Human Herpesvirus 2
Sexually Transmitted Diseases
Public Health
Antibodies
Sexual Behavior
Acyclovir
Population
Prescriptions
Demography
Education
Costs and Cost Analysis
Serum

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Implementation of routine access to herpes simplex virus type 2 antibody testing in a public health sexually transmitted disease clinic. / Fife, Kenneth; Van Der Pol, Barbara; Roth, Alexis M.; Brand, Juanita; Arno, Janet; Madlem, Jyl; Juliar, Beth E.; Katz, Barry; Williams, James A.; Zimet, Gregory; Fortenberry, J.

In: Sexually Transmitted Diseases, Vol. 36, No. 11, 2009, p. 724-728.

Research output: Contribution to journalArticle

Fife, Kenneth ; Van Der Pol, Barbara ; Roth, Alexis M. ; Brand, Juanita ; Arno, Janet ; Madlem, Jyl ; Juliar, Beth E. ; Katz, Barry ; Williams, James A. ; Zimet, Gregory ; Fortenberry, J. / Implementation of routine access to herpes simplex virus type 2 antibody testing in a public health sexually transmitted disease clinic. In: Sexually Transmitted Diseases. 2009 ; Vol. 36, No. 11. pp. 724-728.
@article{46e17f56f30b43fc8890c4984dc2fa3d,
title = "Implementation of routine access to herpes simplex virus type 2 antibody testing in a public health sexually transmitted disease clinic",
abstract = "BACKGROUND:: Testing for herpes simplex virus type 2 (HSV-2) antibody is not common in clinical practice. Client characteristics associated with HSV-2 rapid antibody test uptake and test positivity were analyzed in clients attending an urban sexually transmitted disease clinic. METHODS:: This optional test was available for $30. The HerpeSelect Express assay was performed on serum. Demographic and behavioral characteristics were compared between clients who requested testing and those who did not and between those who were HSV-2 antibody positive and negative. RESULTS:: In 4 months, 3498 individuals attended the clinic and 443 (12.7{\%}) opted for HSV-2 testing. Clients who were black, younger, or female were less likely to request testing. Recent sexual behavior and self-reported sexual orientation were not associated with uptake of testing. Of the 442 clients with results available, 109 were positive for HSV-2 antibody (24.7{\%}). Women were significantly (P <0.001) more likely to test positive; 42 of 111 (38.4{\%}) versus only 67 of 331 (20.2{\%}) men. A positive HSV-2 antibody test was also associated with increasing age and black race. There was an association with the number of partners in the last 30 days, but no association with the number of partners in the last year. Of the 109 clients who had a positive HSV-2 antibody test, 71 (64.5{\%}) accepted a prescription for suppressive acyclovir therapy. CONCLUSIONS:: Uptake of testing was modest in this population, especially among the highest risk individuals, possibly due to the cost of the test. Improved education regarding HSV-2 and subsidized testing may be needed in the populations that have the highest prevalence in order to encourage testing.",
author = "Kenneth Fife and {Van Der Pol}, Barbara and Roth, {Alexis M.} and Juanita Brand and Janet Arno and Jyl Madlem and Juliar, {Beth E.} and Barry Katz and Williams, {James A.} and Gregory Zimet and J. Fortenberry",
year = "2009",
doi = "10.1097/OLQ.0b013e3181bc9a2f",
language = "English",
volume = "36",
pages = "724--728",
journal = "Sexually Transmitted Diseases",
issn = "0148-5717",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Implementation of routine access to herpes simplex virus type 2 antibody testing in a public health sexually transmitted disease clinic

AU - Fife, Kenneth

AU - Van Der Pol, Barbara

AU - Roth, Alexis M.

AU - Brand, Juanita

AU - Arno, Janet

AU - Madlem, Jyl

AU - Juliar, Beth E.

AU - Katz, Barry

AU - Williams, James A.

AU - Zimet, Gregory

AU - Fortenberry, J.

PY - 2009

Y1 - 2009

N2 - BACKGROUND:: Testing for herpes simplex virus type 2 (HSV-2) antibody is not common in clinical practice. Client characteristics associated with HSV-2 rapid antibody test uptake and test positivity were analyzed in clients attending an urban sexually transmitted disease clinic. METHODS:: This optional test was available for $30. The HerpeSelect Express assay was performed on serum. Demographic and behavioral characteristics were compared between clients who requested testing and those who did not and between those who were HSV-2 antibody positive and negative. RESULTS:: In 4 months, 3498 individuals attended the clinic and 443 (12.7%) opted for HSV-2 testing. Clients who were black, younger, or female were less likely to request testing. Recent sexual behavior and self-reported sexual orientation were not associated with uptake of testing. Of the 442 clients with results available, 109 were positive for HSV-2 antibody (24.7%). Women were significantly (P <0.001) more likely to test positive; 42 of 111 (38.4%) versus only 67 of 331 (20.2%) men. A positive HSV-2 antibody test was also associated with increasing age and black race. There was an association with the number of partners in the last 30 days, but no association with the number of partners in the last year. Of the 109 clients who had a positive HSV-2 antibody test, 71 (64.5%) accepted a prescription for suppressive acyclovir therapy. CONCLUSIONS:: Uptake of testing was modest in this population, especially among the highest risk individuals, possibly due to the cost of the test. Improved education regarding HSV-2 and subsidized testing may be needed in the populations that have the highest prevalence in order to encourage testing.

AB - BACKGROUND:: Testing for herpes simplex virus type 2 (HSV-2) antibody is not common in clinical practice. Client characteristics associated with HSV-2 rapid antibody test uptake and test positivity were analyzed in clients attending an urban sexually transmitted disease clinic. METHODS:: This optional test was available for $30. The HerpeSelect Express assay was performed on serum. Demographic and behavioral characteristics were compared between clients who requested testing and those who did not and between those who were HSV-2 antibody positive and negative. RESULTS:: In 4 months, 3498 individuals attended the clinic and 443 (12.7%) opted for HSV-2 testing. Clients who were black, younger, or female were less likely to request testing. Recent sexual behavior and self-reported sexual orientation were not associated with uptake of testing. Of the 442 clients with results available, 109 were positive for HSV-2 antibody (24.7%). Women were significantly (P <0.001) more likely to test positive; 42 of 111 (38.4%) versus only 67 of 331 (20.2%) men. A positive HSV-2 antibody test was also associated with increasing age and black race. There was an association with the number of partners in the last 30 days, but no association with the number of partners in the last year. Of the 109 clients who had a positive HSV-2 antibody test, 71 (64.5%) accepted a prescription for suppressive acyclovir therapy. CONCLUSIONS:: Uptake of testing was modest in this population, especially among the highest risk individuals, possibly due to the cost of the test. Improved education regarding HSV-2 and subsidized testing may be needed in the populations that have the highest prevalence in order to encourage testing.

UR - http://www.scopus.com/inward/record.url?scp=70350752546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350752546&partnerID=8YFLogxK

U2 - 10.1097/OLQ.0b013e3181bc9a2f

DO - 10.1097/OLQ.0b013e3181bc9a2f

M3 - Article

C2 - 19809384

AN - SCOPUS:70350752546

VL - 36

SP - 724

EP - 728

JO - Sexually Transmitted Diseases

JF - Sexually Transmitted Diseases

SN - 0148-5717

IS - 11

ER -